The National Comprehensive Cancer Network and the NCCN Foundation announced four recipients of the annual Young Investigator Awards. These awards provide funding and study support to some of the most promising early-career cancer researchers from across the 28 leading academic cancer centers that comprise NCCN.
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
